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Numerous epidemiological studies have consistently linked elevated resting heart rate (RHR) 
with increased risk of cardiovascular disease and all-cause mortality in men and women.  A 10 
beats/min (bpm) increase in RHR is associated with a 6 to 18% increased risk for coronary artery 
disease (CAD), sudden cardiac death, heart failure, stroke and all-cause mortality (1,2) and 
clinical trials have shown that lowering RHR reduces cardiovascular risk (3).  Additionally, 
higher RHR has been associated with an increased likelihood of developing type 2 diabetes 
(T2D).  For example, participants in the highest (> 72.7 bpm) versus lowest RHR quartile (< 
60.1 bpm) had a 60% increased risk of developing T2D over a 9 year follow-up period in the 
Atherosclerosis Risk in Communities study (4).  However, these findings are not always 
consistent as some studies have subsequently reported the association is attenuated when body 
mass index (BMI) and fasting glucose levels are accounted for (5). 
Epidemiological studies report associations between RHR and T2D, they do not inform on causal 
relationships and shared biology, which is crucial to understand underlying common 
mechanisms. A high RHR has been linked to increased sympathetic activity, insulin resistance 
and the development of T2D (6).  However, the development of T2D may lead to metabolic 
sequalae that increase RHR, providing an alternative explanation of the observed associations 
(7).   
 
In this issue, Guo et al. (8) present a study that investigates the genetic correlation of RHR with 
T2D and eight cardiometabolic traits (fasting insulin, fasting glucose, triglycerides, waist-hip-
ratio [WHR], BMI, LDL, TC and HDL) and assesses causal relationships and shared biological 
mechanisms.  The investigators firstly performed a genome-wide association study for RHR in 
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the UK Biobank, and assessed genetic correlations using publicly available GWAS summary 
statistics for T2D and the cardiometabolic traits (9).  They found 437 independent loci for RHR, 
327 of which were novel.  They found RHR was genetically correlated to T2D (rg = 0.22, P = 2 x 
10
-22
) and with varying degrees to 6 of the cardiometabolic traits studied (fasting insulin, fasting 
glucose, WHR, BMI and triglycerides) with a negative correlation with HDL.  The observed 
correlations were relatively modest, but some were of a similar magnitude to those reported for 
LDL and CAD (rg = 0.25) (9).  To interrogate potential causal relationships they used bi-
directional mendelian randomization (MR) using generalized summary data (10). This analysis 
indicated RHR was causally related with increased T2D risk and vice versa:  Exposure to a 10 
bpm increase in RHR was found to be causally related with a 1.12 fold risk of T2D, which is 
similar to the 1.17 fold risk reported in observational studies.  Conversely, the estimated causal 
effect of T2D on RHR was 0.32 bpm, corresponding to per doubling increment in T2D 
prevalence.  Causal associations were also observed between RHR and both BMI and WHR in 
both directions.  Using results from the newly identified RHR loci and published T2D loci, the 
authors explored if there were any genes whose expression is related to RHR and 
T2D/cardiometabolic traits using a transcriptome-wide association study (TWAS) and if any of 
the genes were common to both traits.  A TWAS is a statistical test that leverages expression 
datasets to identify genes whose expression is correlated with a trait of interest.  Several genes 
and tissues were highlighted for RHR, providing new information on potential candidate genes 
and biology of RHR.  There were 135 TWAS genes shared between RHR and 
T2D/cardiometabolic traits in tissues from the nervous cardiovascular and immune systems, 




A primary observation from this study was the causal associations reported for RHR and T2D 
and vice versa, with the stronger causal association being from RHR to T2D.  Interpreting MR 
results, which indicate causality in both directions is challenging, and there are limited studies in 
the literature reporting such findings (11). The authors used GSMR, this method utilises variants 
which are strongly associated with the risk factor and it has additional methods you can use to 
account for pleiotropic variants and conditional analyses.  It is not clear in the paper by Guo et al 
what genetic variants were used for the MR analyses for either RHR or T2D/cardiometabolic 
traits and how much variance did these genetic variants explain.  Further checks on heterogeneity 
should be done (for example, MR-PRESSO or MR Steiger) and the bidirectional MR findings 
should be validated in independent datasets (11).  Gene-exposure interactions could also be 
studied, as physical activity is associated with RHR (12).  These additional results would provide 
robust underpinnings for the reported observations and would discern the strength and directions 
of the causal relationships.   
 
With the discovery of 327 novel loci for RHR, the authors interrogated this dataset for candidate 
genes for RHR and identified shared genes whose expression was associated with RHR and 
T2D/ related cardiometabolic traits.  Studying the overlap in gene expression across traits may 
implicate altering the levels of proteins regulating both RHR and cardiometabolic traits, which 
may provide useful insights into the shared etiology between them.  As commented by the 
authors, there were relatively smaller sample sizes for metabolic traits in reference panels for 
certain tissues and this may lead to reduction in power to detect signals with small to moderate 
effects.  Most of the shared genes between RHR and T2D were observed in nervous tissue, and 
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cardiovascular and immune systems.  The results indicated genes involved in glucose 
homeostasis, energy metabolism, and autonomic nervous activity.  One of the candidate genes 
revealed by TWAS was GCKR, which encodes a regulatory protein that inhibits glucokinase in 
liver and pancreatic islet cells and is known to play an important role in the glucose homeostasis.  
Although the authors do not comment on its involvement in modulating RHR, it may be that 
changes in glucose homeostasis also affect cardiac energy homeostasis and metabolic properties, 
which translate into changes in RHR.  Previous studies have suggested several biological 
mechanisms by which sympathetic activation may predispose to T2D.  Findings of overlapping 
genes in nervous tissue provide some support for these hypotheses. For example, sympathetic 
activation may inhibit insulin section from pancreatic β cells and activation of the renin-
angiotensin-aldosterone system, which increases RHR and leads to insulin resistance.  Further 
work will be needed to delve deeper into autonomic mechanisms, like using more specific 
expression data from nervous tissues.  This is especially important, as our current understanding 
regarding RHR and T2D indicates a vicious cycle in causal relations, as relatively high RHR is 
often found together with increased blood pressure, atherogenic blood lipid profile, 
inflammation, obesity, and metabolic syndrome in which elevated RHR and cardiometabolic risk 
factors and high blood pressure may be intermediate accelerators of the vicious cycle.  
 
The work presented in this issue can be viewed as a very first step in untangling the causal 
relationship between RHR, T2D and cardiometabolic disorders.  The results further underline the 
complexity of this relationship.  The bi-directional causality especially raises questions and 
further validation will be necessary before beginning to address any clinical implications of the 
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work.  As the authors state in their limitations, the possibility that RHR is mediating the effect or 
other latent factors on T2D cannot be ruled out.  Functional studies on the shared genes may be 
useful in guiding this process.  The promise of potential drug intervention to lower RHR based 
on MR results is alluring, however the life-long exposure (MR evidence) may not translate to 
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